This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2014.
Company Filing History:
1 out of 1,198 
1 out of 2,530 
Years Active: 2014
Title: Katarzyna Olas: Innovator in Therapeutic Agents
Introduction
Katarzyna Olas is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of therapeutic agents, particularly in the context of amyloid beta-induced cytotoxicity. Her innovative work has led to the development of a unique screening assay that holds promise for identifying effective treatments.
Latest Patents
Katarzyna Olas holds a patent titled "Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro." This invention relates to a cell-based in vitro screening assay designed to identify and select therapeutic agents that inhibit amyloid β-induced cytotoxicity. This patent represents a crucial advancement in the search for effective therapies against conditions associated with amyloid beta.
Career Highlights
Throughout her career, Katarzyna has worked with notable companies, including Baxter Healthcare SA and Baxter International Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in medical research.
Collaborations
Katarzyna has collaborated with esteemed colleagues, including Birgit Maria Reipert and Hans-Peter Schwarz. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Katarzyna Olas is a trailblazer in the field of therapeutic agents, with a focus on combating amyloid beta-induced cytotoxicity. Her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.